Intensive systolic blood pressure targets may be cost-effective across most measurement error possibilities

1. In this microsimulation model of patients with high cardiovascular risk, an intensive systolic blood pressure (SBP) target of <120 mm Hg was found to be cost-effective across many levels of measurement error. 2. More aggressive SBP targets were associated with lower cardiovascular disease event rates but higher rates of severe adverse events. Evidence Rating […]